MTH1-IN-2

• UNSPSC Description:

  MTH1-IN-2 is a MutT homolog 1 (MTH1) inhibitor extracted from patent WO2016135138A1, Compound (6), MTH1-IN-2 can be used for the research of cancer. Anti-tumor activity[1].

• Target Antigen:

  DNA/RNA Synthesis

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/mth1-in-2.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CNC2=C(C=C(S(=O)(NC3=CC=CC(OC)=C3)=O)C=C2)C1=O)NC4C(C)CCCC4

• Molecular Weight:

  469.55

• References & Citations:

  [1]Kilian Huber. Oxoquinoline derivatives as mth1 inhibitors for the therapy of cancer. WO2016135138A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  901044-91-5